↑ Rising
Health
Austin father loses vision after taking Wegovy; questions raised about rare condition
A Texas father's sudden vision loss on Wegovy spotlights rising concerns over a rare eye disorder linked to GLP‑1 drugs
Wegovy
36 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Wegovy
This hub groups 36 separate news trends connected to Wegovy, spanning June 18, 2026 through October 5, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 281 article observations and 270 source signals, led by Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
🔮 fades ✓
Taking Ozempic or Wegovy? 2 New Studies Link GLP-1 Drugs to 2 Unexpected Problems
4 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Nail detachment over four times more common among GLP-1 users, first controlled study finds
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Once described as obesity medicines for 'patients,' GLP-1s are increasingly lifestyle drugs for 'customers'
GLP-1s shift from 'patients' to 'customers' as weight loss trend surges
◼ Archived
Health
🔮 fades ✓
Does GLP-1 use result in significant hair loss?
11 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Hundreds of lawsuits allege GLP-1s like Ozempic, Wegovy, Mounjaro caused vision loss
4 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
The dangerous risks of stopping Ozempic and GLP-1s
18 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs
6 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Large genetic study links GLP-1 receptor activation to improved mental well-being
Genetic link between GLP-1 receptor activation and better mental well‑being sparks new buzz in diabetes drugs
◼ Archived
Business
🔮 fades ✓
Will Wegovy Be A Part D, A Medicare GLP-1 Bridge Drug Or Neither?
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
GLP-1-driven vitamin deficiency linked to rare brain disorder: Study
9 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Popular GLP-1 drugs may trigger a rare, life-threatening brain disorder: study
Popular GLP-1 drugs linked to life-threatening brain disorder and suicidal thoughts after weight regain.
◼ Archived
Health
🔮 fades ✓
Scientists Found a Surprising Effect of Ozempic. It Involves Your Lungs
Weight loss drugs linked to fewer asthma attacks, study finds
◼ Archived
Health
🔮 fades ✓
Weight regain after obesity drugs tied to higher odds of suicidal thoughts in observational study
Weight regain after obesity drugs spikes risk of suicidal thoughts, study finds
◼ Archived
Business
🔮 fades ✓
Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped
Novo’s child obesity win sparks hope, but simultaneous heart‑drug trial cuts cloud its broader pipeline.
◼ Archived
Business
🔮 fades ✓
Novo Nordisk Says Wegovy Shot Helped Children Lose Weight in Trial
A childhood‑obesity drug once reserved for adults now shows weight‑loss promise in kids as young as six.
◼ Archived
Health
🔮 fades ✓
Scientists Discover an Unexpected Mental Health Benefit of Ozempic
Ozempic may boost mental health, sparking debate over GLP‑1 drugs' psychological impact
◼ Archived
Health
🔮 fades ✓
GLP-1 medications may worsen or speed hair loss in some men, study finds
GLP-1 medications may worsen or speed hair loss in some men, study finds.
◼ Archived
Health
🔮 fades ✓
Don’t take GLP-1s? Be prepared to explain yourself.
A surge in GLP‑1 prescriptions turns personal weight‑loss choices into a public debate demanding explanations.
◼ Archived
Health
🔮 fades ✓
Experts call for safer weight loss as concerns grow over GLP-1 use - News-Medical
11 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Unexpected GLP-1 side effect? Studies show the meds may help people with addictions
GLP-1 medications, known for weight loss, are now being studied for their potential to treat addictions.
◼ Archived
Health
New Research Shows a Strong Link Between This GLP Medication and Hair Loss. Experts Weigh In.
New research has linked a popular GLP medication to increased hair loss, sparking discussions among health experts.
◼ Archived
Health
🔮 fades ✓
GLP-1s May Be Working in an Entirely Different Way Than We Thought
New research suggests that popular weight-loss drugs may work differently than previously understood.
◼ Archived
Business
🔮 fades ✓
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?
Novo Nordisk faces intensifying competition from Eli Lilly in the global GLP-1 weight-loss market as its early industry lead faces significant pressure.
◼ Archived
Health
🔮 fades ✓
As of July 1, Medicare Covers Wegovy for Weight Loss at $50 a Month. The Eligibility List Is Short.
4 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Rare eye disorder linked to Ozempic-like medications
Health regulators and legal firms are responding to a linked risk of rare blindness and eye disorders associated with GLP-1 weight-loss medications.
◼ Archived
Health
🔮 fades ✗
GLP-1 drugs linked to 17% drop in worker sick leave, new economic study finds
New economic research identifies a correlation between GLP-1 weight-loss drug usage and a 17% reduction in employee sick leave.
◼ Archived
Health
🔮 holds ✓
Georgia woman part of lawsuit claiming link between GLP-1 weight loss drugs and blindness - WSB-TV
Reports and litigation are emerging over a potential link between GLP-1 weight loss medications and a rare, blinding eye condition.
◼ Archived
Health
🔮 fades ✓
GLP-1’s Reduce Binge Eating Symptoms
Research suggests GLP-1 medications like Ozempic and Wegovy may provide a promising treatment for binge eating disorder.
◼ Archived
Health
🔮 fades ✓
Does stopping a GLP-1 really doom you to regain all the weight?
Research is examining the weight-related consequences of discontinuing GLP-1 medications like Ozempic and Wegovy.
◼ Archived
Health
🔮 fades ✓
She Used Weight-Loss Drugs From a Telehealth Company, Then a GLP-1 Overdose Sent Her to the ER
Rising concerns over GLP-1 weight-loss drug overdoses are linked to dosing errors and the use of telehealth services.
◼ Archived
Business
🔮 fades ✗
11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy
GLP-1 weight loss drugs are being used by a record number of Americans.
◼ Archived
Health
🔮 fades ✓
Wegovy weight loss pill now available in UK
Wegovy has launched a daily oral pill for weight management in the UK, marking a shift from injectable treatments to pharmacy-available medication.
◼ Archived
Health
🔮 fades ✓
Ozempic and Wegovy may strengthen bones in Type 2 diabetes patients, study finds
New study data suggests GLP-1 medications like Ozempic and Wegovy may reduce fracture risks and improve bone health in Type 2 diabetes patients.
◼ Archived
Health
🔮 fades ✓
Ozempic users may be making a major weight-loss mistake, new study suggests
New research indicates a trend of decreased physical activity among individuals using GLP-1 weight loss medications like Ozempic and Wegovy.